PALB2 mRNA expression as a predictive marker in advanced non-small cell lung cancer (NSCLC) patients (p) treated with docetaxel-cisplatin

Por: Karachaliou, N, Berenguer, J, Chaib, I, Serrano, JLR, Bueno, MTM, Sureda, BM, Farinas, SC, Camps, C, Pulla, MP and Rosell, R

---

Publicada: 1 abr 2018

---

---

Filiaciones:
Karachaliou, N:
 Hosp Sagrado Corazon, IOR, Barcelona, Spain

Berenguer, J:
 Quiron Dexeus Univ Inst, Coyote Res Grp, Pangaea Oncol, IOR, Barcelona, Spain

:
 Germans Trias & Pujol Res Inst, Lab Cellular & Mol Biol, IGTP, Badalona, Spain

:
 Hosp Badalona Germans Trias & Pujol, Lab Cellular & Mol Biol, Catalan Inst Oncol ICO Badalona, Badalona, Spain

:
 Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol ICO Badalona, Badalona, Spain

Sureda, BM:
 Hosp Gen Univ Alicante, Alicante, Spain

Farinas, SC:
 Hosp Gen Univ Valencia, Valencia, Spain

Camps, C:
 Hosp Gen Univ Valencia, Valencia, Spain

Pulla, MP:
 Hosp Univ Puerta Hierro, Serv Oncol Med, Madrid, Spain

:
 Hosp Badalona Germans Trias & Pujol, Canc Biol & Precis Med Program, Catalan Inst Oncol ICO Badalona, Germans Trias & Pujol Sci Inst, Barcelona, Spain